Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Open-market sale President and CEO sold 12,500 shares at an average $4.63 ($57,832)
  2. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $4.62 ($46,242)
  3. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $4.97 ($49,741)
  4. 4 Open-market sale President and CEO sold 120,000 shares at an average $5.01 ($600,984)
  5. 4 Open-market sale Vice President,General Counsel sold 21,875 shares at an average $4.83 ($105,616)
  6. 4 Open-market sale Chief Financial Officer sold 18,107 shares at an average $4.51 ($81,682)
  7. 4 Open-market buy Director bought 60,975 shares at an average $4.07 ($248,140)
  8. 4 Open-market sale Chief Financial Officer sold 11,250 shares at $4.55 ($51,188)
  9. 4 Open-market sale Vice President,General Counsel sold 6,250 shares at $4.25 ($26,563)
  10. 4 Exercise or conversion Director acquired 65,625 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 20 of 24 · 475 filings